Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tweedy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Nurse Practitioners|October 18, 2000
Polycystic ovary syndromeA Tweedy
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 13, 2002
Performance of the provider satisfaction inventory to measure provider satisfaction with diabetes careVictor M Montori, Deborah A Tweedy, Debra A Vogelsang, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Nurse Practitioners|October 18, 2000
Polycystic ovary syndromeA Tweedy
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 13, 2002
Performance of the provider satisfaction inventory to measure provider satisfaction with diabetes careVictor M Montori, Deborah A Tweedy, Debra A Vogelsang, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Pageof 1